Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
Clinical trial NCT01332721 · COMPLETED
Trial details
- NCT number
- NCT01332721
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2012-09-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.